metformin has been researched along with Neutropenia in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Neutropenia: A decrease in the number of NEUTROPHILS found in the blood.
Excerpt | Relevance | Reference |
---|---|---|
"Metformin was discontinued on day 22 (16 days after reintroduction) and neutropenia promptly reversed during next week with 1." | 5.35 | Auto-immune neutropenia associated with metformin in a patient with splenic marginal zone lymphoma. ( Hamdi, S; Huguet, F; Laporte, F; Oksman, F, 2008) |
"Metformin was discontinued on day 22 (16 days after reintroduction) and neutropenia promptly reversed during next week with 1." | 1.35 | Auto-immune neutropenia associated with metformin in a patient with splenic marginal zone lymphoma. ( Hamdi, S; Huguet, F; Laporte, F; Oksman, F, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Laporte, F | 1 |
Hamdi, S | 1 |
Oksman, F | 1 |
Huguet, F | 1 |
1 other study available for metformin and Neutropenia
Article | Year |
---|---|
Auto-immune neutropenia associated with metformin in a patient with splenic marginal zone lymphoma.
Topics: Aged; Antineoplastic Agents; Autoimmune Diseases; Granulocytes; Humans; Hypoglycemic Agents; Leukocy | 2008 |